Welcome to our dedicated page for BlackRock Credit Allocation SEC filings (Ticker: BTZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock Credit Allocation's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock Credit Allocation's regulatory disclosures and financial reporting.
Arthur Philip Steinmetz, a director of BlackRock Credit Allocation Income Trust (BTZ), reported a transaction dated 10/01/2025 on Form 4. The filing shows the acquisition of 1,054.3 performance rights accrued under the BlackRock Deferred Compensation Plan; each right is convertible into the cash value of one share of the trust. The performance rights are to be settled 100% in cash at the deferral period chosen by the reporting person. The entry lists a price of $11.03 and indicates 9,362.16 shares/units beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025. The filing contains no other transactions, amendments, or additional compensation details.
Catherine A. Lynch, a Director of BlackRock Credit Allocation Income Trust (BTZ), reported on Form 4 that she acquired 21.6 Performance Rights on 10/01/2025 under the BlackRock Deferred Compensation Plan. Each Performance Right is convertible into the cash value of one share of the issuer and the awards are to be settled 100% in cash at the deferral period selected by the reporting person. The filing shows a per‑unit monetary reference of $11.03 and is signed by an attorney‑in‑fact on 10/03/2025. The report indicates these are non‑derivative/derivative compensation awards accrued as part of director compensation rather than open‑market purchases or sales.
Robert Glenn Hubbard, a director of BlackRock Credit Allocation Income Trust (BTZ), reported an acquisition on 10/01/2025 of 969.78 performance rights under the BlackRock Deferred Compensation Plan. Each performance right is convertible into the cash value of one BTZ share and, per the filer, the awards are to be settled 100% in cash at the deferral date chosen by the reporting person. The filing lists 73,595.4 as the number of underlying common shares equivalent reported after the transaction and shows a per-right price reference of $11.03. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
BlackRock Credit Allocation Income Trust (BTZ) director Stayce D. Harris reported acquiring 766.12 performance rights on 10/01/2025. The filing shows each Performance Right is convertible into the cash value of one share and the rights are to be settled 100% in cash at the deferral date chosen by the reporting person. The reported price associated with the derivative entry is $11.03 and following the transaction the reporting person beneficially owns 15,761.88 shares (direct). The Performance Rights were accrued under the BlackRock Deferred Compensation Plan and are intended to satisfy internal compensation deferral rules.
James Phillip Holloman, a director of BlackRock Credit Allocation Income Trust (BTZ), reported a non-derivative change and a derivative grant on 10/01/2025. He received 824.31 Performance Rights under the BlackRock Deferred Compensation Plan; each right converts into the cash value of one share of BTZ and the award is to be settled 100% in cash at the chosen deferral date. The filing shows a price of $11.03 and indicates beneficial ownership of 16,837.46 shares following the transaction. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Flores Lorenzo, a director of BlackRock Credit Allocation Income Trust (BTZ), reported a grant of 659.45 Performance Rights on 10/01/2025. The filing states each Performance Right is convertible into the cash value of one share of BTZ and will be settled 100% in cash at the deferral date chosen by the reporting person under the BlackRock Deferred Compensation Plan. The report shows the reporting person currently beneficially owns 16,118.04 shares (direct).
FAQ
What is the current stock price of BlackRock Credit Allocation (BTZ)?
What is the market cap of BlackRock Credit Allocation (BTZ)?
